Why You Should Buy Moderna (MRNA) Stock On Every Dip
Far from a one-trick pony, shareholders will benefit from holding it for many years.
Read MorePosted by Chris Lau, Investor Place | Dec 11, 2021
Far from a one-trick pony, shareholders will benefit from holding it for many years.
Read MorePosted by Chris Lau, Investor Place | Dec 6, 2021
The company has overcome many obstacles before, it has a strong history of reporting revenue growth, and a quality score that reflects good return on investment.
Read MorePosted by Chris Lau, Investor Place | Nov 2, 2021
The market is underestimating its growth potential. Value investors should accumulate shares at current levels.
Read MorePosted by Chris Lau, Investor Place | Oct 22, 2021
The company is well-positioned to benefit from its recent deals, and “buy on the dip” investors have the chance to accumulate it.
Read MorePosted by Chris Lau, Investor Place | Oct 21, 2021
The markets are ignoring this sleeping giant… it’s time to give it a look again.
Read More